Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Vazirani Asset Management LLC

Q4 2024 · 13F-HR

Vazirani Asset Management LLCholdings as filed

Filed 2025-02-14 · accession 0001085146-25-001631

$32.2M
Reported value
19
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
83200N103SMARGBPSMARTSHEET INC$6.7M20.9%120,000CommonSOLE
487836108KKELLANOVA$5.3M16.3%65,000CommonSOLE
418100103HCP2EURHASHICORP INC$4.8M14.8%135,500CommonSOLE
254709108DFSEURDISCOVER FINL SVCS$4.4M13.8%25,621CommonSOLE
48203R104JNPJUNIPER NETWORKS INC$3.7M11.6%100,000CommonSOLE
457679108INNOVID CORP$1.5M4.79%500,000CommonSOLE
761330109RVNCEURREVANCE THERAPEUTICS INC$1.1M3.30%350,000CommonSOLE
023436108AMEDAMEDISYS INC$907,9002.82%10,000CommonSOLE
577096100MTTR*MATTERPORT INC$834,7502.59%151,500CommonSOLE
42809H107HESHESS CORP$665,0502.06%5,000CommonSOLE
60938K304MONEYLION INC$645,0752.00%7,500CommonSOLE
05591L115BM TECHNOLOGIES INC$437,6491.36%751,328CommonSOLE
690045109REVELYST INC$288,4500.89%15,000CommonSOLE
89854H102TTECTTEC HLDGS INC$249,5000.77%50,000CommonSOLE
008064107AEROVATE THERAPEUTICS INC$198,7500.62%75,000CommonSOLE
60938K114MONEYLION INC$182,8000.57%1,000,000CommonSOLE
07134L107BATLBATTALION OIL CORP$147,4570.46%85,731CommonSOLE
29668H708EPIEURESSA PHARMA INC$89,5000.28%50,000CommonSOLE
45175G108IKENA ONCOLOGY INC$41,0000.13%25,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.